<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.450">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>talks - Chemotherapy and Sarcopenia</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>

  <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg navbar-dark ">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">talks</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Search"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html" rel="" target="">
 <span class="menu-text">Home</span></a>
  </li>  
  <li class="dropdown-header">
 <span class="menu-text">about.qmd</span></li>
</ul>
            <div class="quarto-navbar-tools ms-auto">
</div>
          </div> <!-- /navcollapse -->
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#chemotherapy-and-elderly---adjuvant" id="toc-chemotherapy-and-elderly---adjuvant" class="nav-link active" data-scroll-target="#chemotherapy-and-elderly---adjuvant">Chemotherapy and Elderly - Adjuvant</a></li>
  <li><a href="#chemotherapy-and-elderly---stage-iv" id="toc-chemotherapy-and-elderly---stage-iv" class="nav-link" data-scroll-target="#chemotherapy-and-elderly---stage-iv">Chemotherapy and Elderly - Stage IV</a>
  <ul class="collapse">
  <li><a href="#targeted-therapy-and-elderly" id="toc-targeted-therapy-and-elderly" class="nav-link" data-scroll-target="#targeted-therapy-and-elderly">Targeted therapy and Elderly</a></li>
  </ul></li>
  <li><a href="#frailty-and-chemotherapy" id="toc-frailty-and-chemotherapy" class="nav-link" data-scroll-target="#frailty-and-chemotherapy">Frailty and Chemotherapy</a></li>
  <li><a href="#colorectal-cancer-in-elderly" id="toc-colorectal-cancer-in-elderly" class="nav-link" data-scroll-target="#colorectal-cancer-in-elderly">Colorectal Cancer in Elderly</a>
  <ul class="collapse">
  <li><a href="#adjuvant-5fu-in-colon-cancer" id="toc-adjuvant-5fu-in-colon-cancer" class="nav-link" data-scroll-target="#adjuvant-5fu-in-colon-cancer">Adjuvant 5FU in Colon cancer</a></li>
  <li><a href="#adjuvant-oxaliplatin-in-colon-cancer" id="toc-adjuvant-oxaliplatin-in-colon-cancer" class="nav-link" data-scroll-target="#adjuvant-oxaliplatin-in-colon-cancer">Adjuvant Oxaliplatin in Colon cancer</a></li>
  </ul></li>
  <li><a href="#resources" id="toc-resources" class="nav-link" data-scroll-target="#resources">Resources</a></li>
  <li><a href="#bmi-and-survival-in-stage-iv-cancer" id="toc-bmi-and-survival-in-stage-iv-cancer" class="nav-link" data-scroll-target="#bmi-and-survival-in-stage-iv-cancer">BMI and survival in stage IV cancer</a></li>
  <li><a href="#performance-status-and-chemo" id="toc-performance-status-and-chemo" class="nav-link" data-scroll-target="#performance-status-and-chemo">Performance status and chemo</a>
  <ul class="collapse">
  <li><a href="#undertreatment-of-elderly" id="toc-undertreatment-of-elderly" class="nav-link" data-scroll-target="#undertreatment-of-elderly">Undertreatment of Elderly</a></li>
  </ul></li>
  <li><a href="#age-and-receipt-of-chemotherapy" id="toc-age-and-receipt-of-chemotherapy" class="nav-link" data-scroll-target="#age-and-receipt-of-chemotherapy">Age and receipt of chemotherapy</a></li>
  <li><a href="#platelet-neutrophil-leukocytes" id="toc-platelet-neutrophil-leukocytes" class="nav-link" data-scroll-target="#platelet-neutrophil-leukocytes">Platelet Neutrophil Leukocytes</a></li>
  <li><a href="#immunotherapy-in-frail-patients" id="toc-immunotherapy-in-frail-patients" class="nav-link" data-scroll-target="#immunotherapy-in-frail-patients">Immunotherapy in Frail patients</a></li>
  <li><a href="#reporting" id="toc-reporting" class="nav-link" data-scroll-target="#reporting">Reporting</a></li>
  <li><a href="#palliative-care-consultations" id="toc-palliative-care-consultations" class="nav-link" data-scroll-target="#palliative-care-consultations">Palliative Care consultations</a></li>
  <li><a href="#enteral-nutrition-in-cancer-patients" id="toc-enteral-nutrition-in-cancer-patients" class="nav-link" data-scroll-target="#enteral-nutrition-in-cancer-patients">Enteral nutrition in cancer patients</a></li>
  <li><a href="#section" id="toc-section" class="nav-link" data-scroll-target="#section"></a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Chemotherapy and Sarcopenia</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<section id="chemotherapy-and-elderly---adjuvant" class="level1">
<h1>Chemotherapy and Elderly - Adjuvant</h1>
</section>
<section id="chemotherapy-and-elderly---stage-iv" class="level1">
<h1>Chemotherapy and Elderly - Stage IV</h1>
<p>Colorectal cancer: 1013 patients with Stage IV CRC compared &lt;70 vs 70+. Older patients less likely to receive chemotherapy but among those that did receive chemo, improvement in survival was seen in both the older and younger groups <span class="citation" data-cites="chan147">(<a href="#ref-chan147" role="doc-biblioref">Chan et al. 2017</a>)</span></p>
<p>Colorectal: Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, Barcelo R, Cervantes A, André T, Colin P, et al.&nbsp;FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer. 2007;110:2666–2671.</p>
<p>For frail patients, either 5FU alone or stop and to strategy</p>
<section id="targeted-therapy-and-elderly" class="level3">
<h3 class="anchored" data-anchor-id="targeted-therapy-and-elderly">Targeted therapy and Elderly</h3>
</section>
</section>
<section id="frailty-and-chemotherapy" class="level1">
<h1>Frailty and Chemotherapy</h1>
<p>Chemotherapy in frail patients:</p>
<p>Choosing Wisely <span class="citation" data-cites="schnipper10">(<a href="#ref-schnipper10" role="doc-biblioref">Schnipper et al., n.d.</a>)</span></p>
<p>ASCO statement <span class="citation" data-cites="hurria3826">(<a href="#ref-hurria3826" role="doc-biblioref">Hurria et al. 2015</a>)</span></p>
<p>Cancer patients in the UK have worse survival likely due to undertreatment after age 65 - editorial <span class="citation" data-cites="chanda">(<a href="#ref-chanda" role="doc-biblioref"><strong>chanda?</strong></a>)</span></p>
</section>
<section id="colorectal-cancer-in-elderly" class="level1">
<h1>Colorectal Cancer in Elderly</h1>
<p>Colorectal cancer. Estimated cases in US: 148,000 cases per year, of whom 80,000 are over age 65</p>
<p>NCDB of colon cancer: less adherence to treatment guidelines in elderly patients <span class="citation" data-cites="chen3395">(<a href="#ref-chen3395" role="doc-biblioref">Chen et al. 2020</a>)</span></p>
<p>Stage IV colon cancer over age 75: Equivalent response rates in patients older than 75 and younger. <span class="citation" data-cites="rosati578">(<a href="#ref-rosati578" role="doc-biblioref">Rosati et al. 2019</a>)</span></p>
<p>Meta-analysis of 13 trials of palliative chemotherapy in advanced colorectal cancer showed that chemotherapy for colorectal cancer improves survival by 3.7months and results in improvement of survival of 16% at both 6 and 12 months. ECOG 3/4 only comprise &lt;10% of the total sample of trial participants.<span class="citation" data-cites="simmonds531">(<a href="#ref-simmonds531" role="doc-biblioref">Simmonds 2000</a>)</span></p>
<p>PS2 patients with stage IV CRC have survival less than half that of those with PS of 0 at presentation <span class="citation" data-cites="lavin1536">(<a href="#ref-lavin1536" role="doc-biblioref">Lavin et al. 1980</a>)</span> <span class="citation" data-cites="kemeny786">(<a href="#ref-kemeny786" role="doc-biblioref">Kemeny and Braun 1983</a>)</span></p>
<p>ECOG2 patients receiving first-line chemotherapy for CRC had 12% 60-day morality <span class="citation" data-cites="sargent1948">(<a href="#ref-sargent1948" role="doc-biblioref">Sargent et al. 2009</a>)</span></p>
<p>Kohorana Score for CRC early death: (primary site, baseline hemoglobin, leukocyte and platelet counts, BMI) <span class="citation" data-cites="khorana4902">(<a href="#ref-khorana4902" role="doc-biblioref">Khorana et al. 2008</a>)</span></p>
<p>Stage IV CRC prognostic model: [chibaudel1228] = f(performance status, LDH,number of metastatic sites). Serum LDH most prognostic factor, followed by PS</p>
<p>Kohne model: PS, WBC, ALP, number of metastatic sites <span class="citation" data-cites="kohne308">(<a href="#ref-kohne308" role="doc-biblioref">Köhne et al. 2002</a>)</span></p>
<section id="adjuvant-5fu-in-colon-cancer" class="level3">
<h3 class="anchored" data-anchor-id="adjuvant-5fu-in-colon-cancer">Adjuvant 5FU in Colon cancer</h3>
<p>Adjuvant 5FU appears beneficial in the elderly Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, Shepherd LE, Seitz JF, Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345:1091–1097</p>
<p>McCleary - ACCENT group analysis</p>
</section>
<section id="adjuvant-oxaliplatin-in-colon-cancer" class="level3">
<h3 class="anchored" data-anchor-id="adjuvant-oxaliplatin-in-colon-cancer">Adjuvant Oxaliplatin in Colon cancer</h3>
<p>Addition of oxaliplatin to 5FU results in survival benefit for younger patients but may not be of benefit to elderly patients</p>
</section>
</section>
<section id="resources" class="level1">
<h1>Resources</h1>
<p>Dalane Kitzman - https://www.wakehealth.edu/providers/k/dalane-w-kitzman dkitzman@wakehealth.edu</p>
</section>
<section id="bmi-and-survival-in-stage-iv-cancer" class="level1">
<h1>BMI and survival in stage IV cancer</h1>
<p>Low BMI may be associated with high cancer-specific mortality (Renfro LA, Loupakis F, Adams RA. et al.&nbsp;Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol. 2016;34(2):144–150. 10.1200/JCO.2015.61.6441) High BMI may be an indicator of co-morbidities and may be associated with high non-cancer mortality ( Lee J, Meyerhardt JA, Giovannucci E, Jeon JY.. Association between body mass index and prognosis of colorectal cancer: A meta-analysis of prospective cohort studies. PLoS One. 2015;10:e0120706.) Visceral adiposity is associated with higher mortality in patients undergoing adjuvant chemotherapy (Lee CS, Murphy DJ, McMahon C, et al.&nbsp;Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy. J Gastrointest Cancer. 2015;46(3):243–250. 10.1007/s12029-015-9709-0)</p>
</section>
<section id="performance-status-and-chemo" class="level1">
<h1>Performance status and chemo</h1>
<p>Clinical trials typically enroll less than 10% of patients with PS of 2</p>
<p>ECOG may be less accurate in the low end of the scale <span class="citation" data-cites="verger1328">(<a href="#ref-verger1328" role="doc-biblioref"><strong>verger1328?</strong></a>)</span></p>
<p>Low inter-observer agreement (J. Myers, K. Gardiner, K. Harris et al., “Evaluating correlation and interrater reliability for four performance scales in the palliative care setting,” Journal of Pain and Symptom Management, vol.&nbsp;39, no. 2, pp.&nbsp;250–258, 2010.)</p>
<p>Poor inter-observer agreement of ECOG, with oncolgist and nurses recording higher values than patients (M. Ando, Y. Ando, Y. Hasegawa et al., “Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer,” British Journal of Cancer, vol.&nbsp;85, no. 11, pp.&nbsp;1634–1639, 2001)</p>
<p>Interobserver agreement between patient and oncologist 50% in lung cancer (S. P. Blagden, S. C. Charman, L. D. Sharples, L. R. A. Magee, and D. Gilligan, “Performance status score: do patients and their oncologists agree?” British Journal of Cancer, vol.&nbsp;89, no. 6, pp.&nbsp;1022–1027, 2003.)</p>
<p>M.M. Oken, R.H. Creech, D.C. Tormey, et al.&nbsp;Toxicity and response criteria of the eastern cooperative oncology group Am. J. Clin. Oncol., 5 (1982), pp.&nbsp;649-655</p>
<p>R. Chow, N. Chiu, E. Bruera, et al.&nbsp;Inter-rater reliability in performance status assessment among health care professionals: a systematic review Ann. Palliat. Med., 5 (2016), pp.&nbsp;83-92</p>
<p>All-cause mortality risk prediction in geriatric oncology <span class="citation" data-cites="perez-de-acha1377">(<a href="#ref-perez-de-acha1377" role="doc-biblioref">Perez-de-Acha, Pilleron, and Soto-Perez-de-Celis 2022</a>)</span> Predicting life expectancy in older adults with cancer <span class="citation" data-cites="verduzco-aguirre68">(<a href="#ref-verduzco-aguirre68" role="doc-biblioref">Verduzco-Aguirre et al. 2019</a>)</span></p>
<p>Functional vs chronological age<span class="citation" data-cites="soto-perez-de-celise305">(<a href="#ref-soto-perez-de-celise305" role="doc-biblioref">Soto-Perez-de-Celis et al. 2018</a>)</span></p>
<section id="undertreatment-of-elderly" class="level2">
<h2 class="anchored" data-anchor-id="undertreatment-of-elderly">Undertreatment of Elderly</h2>
<p>Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. Lancet. 2000;356:968–974</p>
<p>Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850–857</p>
<p>Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192–1202.</p>
<p>Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002;136:349–357</p>
<p>Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703–2711.</p>
<p>110 CRC patients over age 75: only 6/23 received adjuvant chemotherapy. Out of 18 patients with stage IV disease, only 3 received palliative chemotherapy. Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D, Mion M, Choudat L, Sobhani I, Mentré F, Soulé JC. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol. 2009;71:249–257</p>
<p>Adjuvant chemotherapy for stage III colon cancer appears to be efficacious in the elderly: Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002;20:3992–3998</p>
<p>Age and oncologist decisions <span class="citation" data-cites="foster584">(<a href="#ref-foster584" role="doc-biblioref">Foster et al. 2010</a>)</span></p>
<p>Age and comorbidity affect recommendations for chemotherapy in stage III colon cancer - more variability of recommendation for older patients<span class="citation" data-cites="keating2532">(<a href="#ref-keating2532" role="doc-biblioref">Keating et al. 2008</a>)</span></p>
</section>
</section>
<section id="age-and-receipt-of-chemotherapy" class="level1">
<h1>Age and receipt of chemotherapy</h1>
<p>H. K. Sanoff, W. R. Carpenter, T. Sturmer et al.&nbsp;et al., “Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years,” Journal of Clinical Oncology, vol.&nbsp;30, no. 21, pp.&nbsp;2624–2634, 2012 D. Schrag, L. D. Cramer, P. B. Bach, and C. B. Begg, “Age and adjuvant chemotherapy use after surgery for stage III colon cancer,” Journal of the National Cancer Institute, vol.&nbsp;93, no. 11, pp.&nbsp;850–857, 2001.</p>
<p>Older patients do derive benefit from chemotherapy H. B. Muss, S. Woolf, D. Berry et al., “Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer,” The Journal of the American Medical Association, vol.&nbsp;293, no. 9, pp.&nbsp;1073–1081, 2005.</p>
<p>Older adults &gt;70 are less likely to be enrolled in 2nd line trials for</p>
</section>
<section id="platelet-neutrophil-leukocytes" class="level1">
<h1>Platelet Neutrophil Leukocytes</h1>
<p><span class="citation" data-cites="mercier478">(<a href="#ref-mercier478" role="doc-biblioref">Mercier and Voutsadakis 2018</a>)</span></p>
<p>Tan D, Fu Y, Su Q, et al.&nbsp;Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e3837.</p>
<p>Li MX, Liu XM, Zhang XF, et al.&nbsp;Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Int J Cancer 2014;134:2403-13.</p>
</section>
<section id="immunotherapy-in-frail-patients" class="level1">
<h1>Immunotherapy in Frail patients</h1>
<p>Creighton: <span class="citation" data-cites="krishnane175">(<a href="#ref-krishnane175" role="doc-biblioref">Krishnan et al. 2022</a>)</span> 257 patients with advanced solid tumor receiving immune checkpoint inhibitors. 182 were ECOG 0-1 and 75 were ECOG &gt;=2. Median overall survival was 12.6 months for the ECOG PS 0-1 group compared with 3.1 months for the ECOG PS ≥ 2 group (P &lt; .001). The overall response rate for patients with ECOG PS 0-1 was 23% compared with 8% for those with poor PS (P = .005). Patients with poor PS treated with ICI had similar hospice referral rates (67% for ECOG PS ≥ 2 v 61.9% for ECOG PS 0-1, P = .50) but were more likely to have in-hospital death as compared with the good PS group (28.6% v 15.1%, P = .035).</p>
<p>India: <span class="citation" data-cites="kapoore25115">(<a href="#ref-kapoore25115" role="doc-biblioref">Kapoor et al. 2021</a>)</span> 155 patients receiving ICIs. ECOG 0-1 had median survival 9.1 months vs 2.9months in ECOG 2-4. Median OS for ECOG2 was 3.7months vs 1.8 months with ECOG 3-4</p>
<p>Meta-analysis of IC trials: No difference in benefit for ECOG 0 vs ECOG &gt;=1 <span class="citation" data-cites="yange2012534">(<a href="#ref-yange2012534" role="doc-biblioref">Yang et al. 2020</a>)</span></p>
<p>Melanoma PS2-3 treated with ICI had median survival of 18 months vs 19.5 months for ECOG 0-1 <span class="citation" data-cites="wong385">(<a href="#ref-wong385" role="doc-biblioref">Wong et al. 2017</a>)</span></p>
<p>Lung cancer with ECOG 2+ had worse prognosis than ECOG 0-1 in NSCLC treated with pembro <span class="citation" data-cites="sehgale2037120">(<a href="#ref-sehgale2037120" role="doc-biblioref"><strong>sehgale2037120?</strong></a>)</span></p>
<p>NSCLC treated with ICI: shorter survival in ECOG 2+ compared with PS 0-1 <span class="citation" data-cites="petrillo2288">(<a href="#ref-petrillo2288" role="doc-biblioref">Petrillo et al. 2020</a>)</span></p>
<p>NSCLC meta-analysis of ECOG 2: <span class="citation" data-cites="tomasik97">(<a href="#ref-tomasik97" role="doc-biblioref">Tomasik et al. 2021</a>)</span> Patients with impaired PS are twice as likely to achieve a response compared with ECOG 0-1</p>
<p>France <span class="citation" data-cites="facchinetti155">(<a href="#ref-facchinetti155" role="doc-biblioref">Facchinetti et al. 2020</a>)</span> 153 patients ECOG 2. Patients who were ECOG 2 due to comorbidities (n=41) had much better prognosis (median survival 11.8 vs 2.8 months) than those ECOG 2 due to disease burden(n=112)</p>
<p>Checkpoint inhibitor dose in the last 30 days of life associated with poor PS and dying in hospital <span class="citation" data-cites="bloome849">(<a href="#ref-bloome849" role="doc-biblioref">Bloom et al. 2022</a>)</span></p>
<p>Risk-adjusting Toxicity of chemotherapy</p>
<ol start="11" type="1">
<li>Hurria A, Togawa K, Mohile SG, et al.&nbsp;Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study. J Clin Oncol. 2011;29:3457–3465.</li>
</ol>
</section>
<section id="reporting" class="level1">
<h1>Reporting</h1>
<p>Benchimol EI, Smeeth L, Guttmann A, et al.&nbsp;The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https://doi.org/10.1371/journal.pmed.1001885 . - DOI - PubMed - PMC</p>
</section>
<section id="palliative-care-consultations" class="level1">
<h1>Palliative Care consultations</h1>
<p>VA System: <span class="citation" data-cites="sullivan1702">(<a href="#ref-sullivan1702" role="doc-biblioref">Sullivan et al. 2019</a>)</span> Lung Cancer - palliative care consultation 31-365 days after dx led to increased survival</p>
</section>
<section id="enteral-nutrition-in-cancer-patients" class="level1">
<h1>Enteral nutrition in cancer patients</h1>
<p>In 347 stage IV gastric cancer patients at high nutrition risk and receiving palliative CT, nutritional support was associated with a survival benefit 39.Qiu M, ZhouYX, Jin Y, Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer. 2015: 23; 1933. -9 Esophageal cancer patients RCT enteral therapy vs oral nutrition <span class="citation" data-cites="lyu839516">(<a href="#ref-lyu839516" role="doc-biblioref">Lyu et al. 2022</a>)</span></p>
</section>
<section id="section" class="level1">




</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents" role="doc-bibliography"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent" role="list">
<div id="ref-bloome849" class="csl-entry" role="listitem">
Bloom, Matthew D., Haneen Saker, Chad Glisch, Brian Ramnaraign, Thomas J. George, Merry J. Markham, and Amar H. Kelkar. 2022. <span>“Administration of <span>Immune Checkpoint Inhibitors Near</span> the <span>End</span> of <span>Life</span>.”</span> <em>JCO Oncology Practice</em> 18 (6): e849–56. <a href="https://doi.org/10.1200/OP.21.00689">https://doi.org/10.1200/OP.21.00689</a>.
</div>
<div id="ref-chan147" class="csl-entry" role="listitem">
Chan, Matthew, Kiara Hugh-Yeun, Gillian Gresham, Caroline H. Speers, Hagen F. Kennecke, and Winson Y. Cheung. 2017. <span>“Population-<span>Based Patterns</span> and <span>Factors Associated With Underuse</span> of <span>Palliative Systemic Therapy</span> in <span>Elderly Patients With Metastatic Colon Cancer</span>.”</span> <em>Clinical Colorectal Cancer</em> 16 (2): 147–53. <a href="https://doi.org/10.1016/j.clcc.2016.08.004">https://doi.org/10.1016/j.clcc.2016.08.004</a>.
</div>
<div id="ref-chen3395" class="csl-entry" role="listitem">
Chen, Fa, Fei Wang, Christina E. Bailey, Harvey J. Murff, Jordan D. Berlin, Xiao-Ou Shu, and Wei Zheng. 2020. <span>“<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642646">Evaluation of Determinants for Age Disparities in the Survival Improvement of Colon Cancer: Results from a Cohort of More Than 486,000 Patients in the <span>United States</span></a>.”</span> <em>American Journal of Cancer Research</em> 10 (10): 3395–405.
</div>
<div id="ref-facchinetti155" class="csl-entry" role="listitem">
Facchinetti, Francesco, Giulia Mazzaschi, Fausto Barbieri, Francesco Passiglia, Francesca Mazzoni, Rossana Berardi, Claudia Proto, et al. 2020. <span>“First-Line Pembrolizumab in Advanced Non-Small Cell Lung Cancer Patients with Poor Performance Status.”</span> <em>European Journal of Cancer (Oxford, England: 1990)</em> 130 (May): 155–67. <a href="https://doi.org/10.1016/j.ejca.2020.02.023">https://doi.org/10.1016/j.ejca.2020.02.023</a>.
</div>
<div id="ref-foster584" class="csl-entry" role="listitem">
Foster, Jill A., Gregory D. Salinas, Dorcas Mansell, James C. Williamson, and Linda L. Casebeer. 2010. <span>“How Does Older Age Influence Oncologists’ Cancer Management?”</span> <em>The Oncologist</em> 15 (6): 584–92. <a href="https://doi.org/10.1634/theoncologist.2009-0198">https://doi.org/10.1634/theoncologist.2009-0198</a>.
</div>
<div id="ref-hurria3826" class="csl-entry" role="listitem">
Hurria, Arti, Laura A. Levit, William Dale, Supriya G. Mohile, Hyman B. Muss, Louis Fehrenbacher, Allison Magnuson, et al. 2015. <span>“Improving the <span>Evidence Base</span> for <span>Treating Older Adults With Cancer</span>: <span>American Society</span> of <span>Clinical Oncology Statement</span>.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 33 (32): 3826–33. <a href="https://doi.org/10.1200/JCO.2015.63.0319">https://doi.org/10.1200/JCO.2015.63.0319</a>.
</div>
<div id="ref-kapoore25115" class="csl-entry" role="listitem">
Kapoor, Akhil, Vanita Noronha, Vijay M. Patil, Nandini Menon, Amit Joshi, George Abraham, and Kumar Prabhash. 2021. <span>“Immune Checkpoint Inhibitors in Patients with Solid Tumors and Poor Performance Status: <span>A</span> Prospective Data from the Real-World Settings.”</span> <em>Medicine</em> 100 (13): e25115. <a href="https://doi.org/10.1097/MD.0000000000025115">https://doi.org/10.1097/MD.0000000000025115</a>.
</div>
<div id="ref-keating2532" class="csl-entry" role="listitem">
Keating, Nancy L., Mary Beth Landrum, Carrie N. Klabunde, Robert H. Fletcher, Selwyn O. Rogers, William R. Doucette, Diana Tisnado, Steven Clauser, and Katherine L. Kahn. 2008. <span>“Adjuvant Chemotherapy for Stage <span>III</span> Colon Cancer: Do Physicians Agree about the Importance of Patient Age and Comorbidity?”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 26 (15): 2532–37. <a href="https://doi.org/10.1200/JCO.2007.15.9434">https://doi.org/10.1200/JCO.2007.15.9434</a>.
</div>
<div id="ref-kemeny786" class="csl-entry" role="listitem">
Kemeny, N., and D. W. Braun. 1983. <span>“Prognostic Factors in Advanced Colorectal Carcinoma. <span>Importance</span> of Lactic Dehydrogenase Level, Performance Status, and White Blood Cell Count.”</span> <em>The American Journal of Medicine</em> 74 (5): 786–94. <a href="https://doi.org/10.1016/0002-9343(83)91066-5">https://doi.org/10.1016/0002-9343(83)91066-5</a>.
</div>
<div id="ref-khorana4902" class="csl-entry" role="listitem">
Khorana, Alok A., Nicole M. Kuderer, Eva Culakova, Gary H. Lyman, and Charles W. Francis. 2008. <span>“Development and Validation of a Predictive Model for Chemotherapy-Associated Thrombosis.”</span> <em>Blood</em> 111 (10): 4902–7. <a href="https://doi.org/10.1182/blood-2007-10-116327">https://doi.org/10.1182/blood-2007-10-116327</a>.
</div>
<div id="ref-kohne308" class="csl-entry" role="listitem">
Köhne, C. H., D. Cunningham, F. Di Costanzo, B. Glimelius, G. Blijham, E. Aranda, W. Scheithauer, et al. 2002. <span>“Clinical Determinants of Survival in Patients with 5-Fluorouracil-Based Treatment for Metastatic Colorectal Cancer: Results of a Multivariate Analysis of 3825 Patients.”</span> <em>Annals of Oncology: Official Journal of the European Society for Medical Oncology</em> 13 (2): 308–17. <a href="https://doi.org/10.1093/annonc/mdf034">https://doi.org/10.1093/annonc/mdf034</a>.
</div>
<div id="ref-krishnane175" class="csl-entry" role="listitem">
Krishnan, Mridula, Pooja Kasinath, Robin High, Fang Yu, and Benjamin A. Teply. 2022. <span>“Impact of <span>Performance Status</span> on <span>Response</span> and <span>Survival Among Patients Receiving Checkpoint Inhibitors</span> for <span>Advanced Solid Tumors</span>.”</span> <em>JCO Oncology Practice</em> 18 (1): e175–82. <a href="https://doi.org/10.1200/OP.20.01055">https://doi.org/10.1200/OP.20.01055</a>.
</div>
<div id="ref-lavin1536" class="csl-entry" role="listitem">
Lavin, P., A. Mittelman, H. Douglass, P. Engstrom, and D. Klaassen. 1980. <span>“Survival and Response to Chemotherapy for Advanced Colorectal Adenocarcinoma: An <span>Eastern Cooperative Oncology Group</span> Report.”</span> <em>Cancer</em> 46 (7): 1536–43. <a href="https://doi.org/10.1002/1097-0142(19801001)46:7<1536::aid-cncr2820460707>3.0.co;2-k">https://doi.org/10.1002/1097-0142(19801001)46:7&lt;1536::aid-cncr2820460707&gt;3.0.co;2-k</a>.
</div>
<div id="ref-lyu839516" class="csl-entry" role="listitem">
Lyu, Jiahua, Anhui Shi, Tao Li, Jie Li, Ren Zhao, Shuchai Zhu, Jianhua Wang, et al. 2022. <span>“Effects of <span>Enteral Nutrition</span> on <span>Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy</span>: <span>A Prospective</span>, <span>Multicentre</span>, <span>Randomised</span>, <span>Controlled Study</span>.”</span> <em>Frontiers in Oncology</em> 12: 839516. <a href="https://doi.org/10.3389/fonc.2022.839516">https://doi.org/10.3389/fonc.2022.839516</a>.
</div>
<div id="ref-mercier478" class="csl-entry" role="listitem">
Mercier, Joey, and Ioannis A. Voutsadakis. 2018. <span>“The Platelets-Neutrophils to Lymphocytes Ratio: A New Prognostic Marker in Metastatic Colorectal Cancer.”</span> <em>Journal of Gastrointestinal Oncology</em> 9 (3): 478–86. <a href="https://doi.org/10.21037/jgo.2018.03.13">https://doi.org/10.21037/jgo.2018.03.13</a>.
</div>
<div id="ref-perez-de-acha1377" class="csl-entry" role="listitem">
Perez-de-Acha, Andrea, Sophie Pilleron, and Enrique Soto-Perez-de-Celis. 2022. <span>“All-<span>Cause Mortality Risk Prediction</span> in <span>Older Adults</span> with <span>Cancer</span>: <span>Practical Approaches</span> and <span>Limitations</span>.”</span> <em>Current Oncology Reports</em> 24 (11): 1377–85. <a href="https://doi.org/10.1007/s11912-022-01303-2">https://doi.org/10.1007/s11912-022-01303-2</a>.
</div>
<div id="ref-petrillo2288" class="csl-entry" role="listitem">
Petrillo, Laura A., Areej El-Jawahri, Ryan D. Nipp, Morgan R. L. Lichtenstein, Sienna M. Durbin, Kerry L. Reynolds, Joseph A. Greer, Jennifer S. Temel, and Justin F. Gainor. 2020. <span>“Performance Status and End-of-Life Care Among Adults with Non<span></span>small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.”</span> <em>Cancer</em> 126 (10): 2288–95. <a href="https://doi.org/10.1002/cncr.32782">https://doi.org/10.1002/cncr.32782</a>.
</div>
<div id="ref-rosati578" class="csl-entry" role="listitem">
Rosati, Gerardo, Stefano Cordio, Giorgio Reggiardo, Giuseppe Aprile, Alfredo Butera, Antonio Avallone, Aniello Tucci, et al. 2019. <span>“Oxaliplatin-<span>Based Chemotherapy</span> in <span>Patients</span> with <span>Metastatic Colorectal Cancer Aged</span> at <span>Least</span> 75 <span>Years</span>: <span>A Post-Hoc Subgroup Analysis</span> of <span>Three Phase II Trials</span>.”</span> <em>Cancers</em> 11 (4): 578. <a href="https://doi.org/10.3390/cancers11040578">https://doi.org/10.3390/cancers11040578</a>.
</div>
<div id="ref-sargent1948" class="csl-entry" role="listitem">
Sargent, Daniel J., Claus Henning Köhne, Hanna Kelly Sanoff, Brian M. Bot, Matthew T. Seymour, Aimery de Gramont, Ranier Porschen, et al. 2009. <span>“Pooled <span>Safety</span> and <span>Efficacy Analysis Examining</span> the <span>Effect</span> of <span>Performance Status</span> on <span>Outcomes</span> in <span>Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer</span>.”</span> <em>Journal of Clinical Oncology</em> 27 (12): 1948–55. <a href="https://doi.org/10.1200/JCO.2008.20.2879">https://doi.org/10.1200/JCO.2008.20.2879</a>.
</div>
<div id="ref-schnipper10" class="csl-entry" role="listitem">
Schnipper, Lowell E, Thomas J Smith, Derek Raghavan, Douglas W Blayney, Patricia A Ganz, Therese Marie Mulvey, and Dana S Wollins. n.d. <span>“American <span>Society</span> of <span>Clinical Oncology Identifies Five Key Opportunities</span> to <span>Improve Care</span> and <span>Reduce Costs</span>: <span>The Top Five List</span> for <span>Oncology</span>.”</span> <em>JOURNAL OF CLINICAL ONCOLOGY</em>, 10.
</div>
<div id="ref-simmonds531" class="csl-entry" role="listitem">
Simmonds, P. C. 2000. <span>“Palliative Chemotherapy for Advanced Colorectal Cancer: Systematic Review and Meta-Analysis. <span>Colorectal Cancer Collaborative Group</span>.”</span> <em>BMJ (Clinical Research Ed.)</em> 321 (7260): 531–35. <a href="https://doi.org/10.1136/bmj.321.7260.531">https://doi.org/10.1136/bmj.321.7260.531</a>.
</div>
<div id="ref-soto-perez-de-celise305" class="csl-entry" role="listitem">
Soto-Perez-de-Celis, Enrique, Daneng Li, Yuan Yuan, Yat Ming Lau, and Arti Hurria. 2018. <span>“Functional Versus Chronological Age: Geriatric Assessments to Guide Decision Making in Older Patients with Cancer.”</span> <em>The Lancet. Oncology</em> 19 (6): e305–16. <a href="https://doi.org/10.1016/S1470-2045(18)30348-6">https://doi.org/10.1016/S1470-2045(18)30348-6</a>.
</div>
<div id="ref-sullivan1702" class="csl-entry" role="listitem">
Sullivan, Donald R., Benjamin Chan, Jodi A. Lapidus, Linda Ganzini, Lissi Hansen, Patricia A. Carney, Erik K. Fromme, et al. 2019. <span>“Association of <span>Early Palliative Care Use With Survival</span> and <span>Place</span> of <span>Death Among Patients With Advanced Lung Cancer Receiving Care</span> in the <span>Veterans Health Administration</span>.”</span> <em>JAMA Oncology</em> 5 (12): 1702–9. <a href="https://doi.org/10.1001/jamaoncol.2019.3105">https://doi.org/10.1001/jamaoncol.2019.3105</a>.
</div>
<div id="ref-tomasik97" class="csl-entry" role="listitem">
Tomasik, Bartłomiej, Michał Bieńkowski, Marcin Braun, Sanjay Popat, and Rafał Dziadziuszko. 2021. <span>“Effectiveness and Safety of Immunotherapy in <span>NSCLC</span> Patients with <span>ECOG PS</span> Score <span><span class="math inline">\(\geq\)</span></span>2 - <span>Systematic</span> Review and Meta-Analysis.”</span> <em>Lung Cancer (Amsterdam, Netherlands)</em> 158 (August): 97–106. <a href="https://doi.org/10.1016/j.lungcan.2021.06.004">https://doi.org/10.1016/j.lungcan.2021.06.004</a>.
</div>
<div id="ref-verduzco-aguirre68" class="csl-entry" role="listitem">
Verduzco-Aguirre, Haydee Cristina, Carolina Gomez-Moreno, Yanin Chavarri-Guerra, and Enrique Soto-Perez-de-Celis. 2019. <span>“Predicting <span>Life Expectancy</span> for <span>Older Adults</span> with <span>Cancer</span> in <span>Clinical Practice</span>: <span>Implications</span> for <span class="nocase">Shared Decision-making</span>.”</span> <em>Current Oncology Reports</em> 21 (8): 68. <a href="https://doi.org/10.1007/s11912-019-0821-3">https://doi.org/10.1007/s11912-019-0821-3</a>.
</div>
<div id="ref-wong385" class="csl-entry" role="listitem">
Wong, Annie, Molly Williams, Donna Milne, Kortnye Morris, Peter Lau, Odette Spruyt, Sonia Fullerton, and Grant McArthur. 2017. <span>“Clinical and Palliative Care Outcomes for Patients of Poor Performance Status Treated with Antiprogrammed Death-1 Monoclonal Antibodies for Advanced Melanoma.”</span> <em>Asia-Pacific Journal of Clinical Oncology</em> 13 (6): 385–90. <a href="https://doi.org/10.1111/ajco.12702">https://doi.org/10.1111/ajco.12702</a>.
</div>
<div id="ref-yange2012534" class="csl-entry" role="listitem">
Yang, Fang, Svetomir N. Markovic, Julian R. Molina, Thorvardur R. Halfdanarson, Lance C. Pagliaro, Ashish V. Chintakuntlawar, Rutian Li, et al. 2020. <span>“Association of <span>Sex</span>, <span>Age</span>, and <span>Eastern Cooperative Oncology Group Performance Status With Survival Benefit</span> of <span>Cancer Immunotherapy</span> in <span>Randomized Clinical Trials</span>: <span>A Systematic Review</span> and <span class="nocase">Meta-analysis</span>.”</span> <em>JAMA Network Open</em> 3 (8): e2012534. <a href="https://doi.org/10.1001/jamanetworkopen.2020.12534">https://doi.org/10.1001/jamanetworkopen.2020.12534</a>.
</div>
</div></section></div></main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>